Prenatal infection, maternal immune activation, and risk for schizophrenia

Articles in the same Issue

1. Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease
2. Building authentic midbrain dopaminergic neurons from stem cells - lessons from development
3. Prenatal infection, maternal immune activation, and risk for schizophrenia
4. Effects of pain on activities of daily living and functioning in Parkinson’s disease patients
5. Homeostatic function of astrocytes: Ca2+ and Na+ signalling
6. Cognitive deficits, obesity and disability in schizophrenia
7. Pathologies of axonal transport in neurodegenerative diseases
8. Translational strategies in peripheral neuroinflammation and neurovascular repair
9. Autophagosomes and multivesicular bodies in neuronal development and degeneration
10. Schizophrenia as a disturbance of cortical sensory maps
11. Neurogenic neuroprotection: Future perspectives
12. Two new gene mutations for late onset mitochondrial neurogastrointestinal encephalopathy (MNGIE)